aXichem AB (A6X.F)
- Previous Close
0.1890 - Open
0.1880 - Bid 0.1870 x --
- Ask 0.2550 x --
- Day's Range
0.1840 - 0.1880 - 52 Week Range
0.0570 - 0.2420 - Volume
955 - Avg. Volume
15 - Market Cap (intraday)
13.086M - Beta (5Y Monthly) -0.26
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0300 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden. It offers aXivite, a natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings and underground cables; and aXiphen-feed, a solution for enhanced health for chickens, hens, pigs, and piglets. The company was founded in 1999 and is based in Malmö, Sweden.
www.axichem.com7
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: A6X.F
更多內容Performance Overview: A6X.F
Trailing total returns as of 6/10/2025, which may include dividends or other distributions. Benchmark is ^OMX (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
比較: A6X.F
選擇以關鍵表現數據分析類似公司；最多可選擇 4 個股份。
Statistics: A6X.F
更多內容Valuation Measures
Market Cap
13.44M
Enterprise Value
12.14M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.39
Price/Book (mrq)
1.79
Enterprise Value/Revenue
14.81
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-164.82%
Return on Assets (ttm)
-14.44%
Return on Equity (ttm)
-28.23%
Revenue (ttm)
11.15M
Net Income Avi to Common (ttm)
-18.38M
Diluted EPS (ttm)
-0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
9.65M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
4.05M